IPP Bureau
Natco announces launch of 10 mg Everolimus in the US
By IPP Bureau - October 01, 2021
According to industry sales data, the 10mg strength of Afinitor generated annual sales of US $ 392 million during the twelve months ending July 2021
Takeda to collaborate with JCR Pharma to commercialise next-gen Hunter Syndrome therapy
By IPP Bureau - October 01, 2021
Takeda to exclusively commercialize JR-141 outside the U.S. (except Japan and certain other Asia-Pacific countries) upon regulatory approval
NASSCOM CoE-IoT announces winners of Healthcare Innovation challenge
By IPP Bureau - October 01, 2021
This one-of-a-kind innovation challenge is aimed at addressing the challenges faced by healthcare providers in digital technology adoption
Merck to acquire Acceleron for US $ 11.5 billion
By IPP Bureau - October 01, 2021
The acquisition complements and strengthens Merck’s cardiovascular pipeline
Merck and Ridgeback’s molnupiravir offer hope to Covid-19 patients
By IPP Bureau - October 01, 2021
If cleared, Merck's drug would be the first pill shown to treat Covid-19, a potentially major advance in efforts to fight the pandemic
Aurobindo Pharma’s subsidiary opens logistics centre in France
By IPP Bureau - September 30, 2021
The site's strategic location in the logistics hubs of the Auvergne Rhone-Alpes region is an advantage, along with the benefit of geographical proximity to Arrow's headquarters in Lyon
WHO new Essential Medicines Lists focus on diabetes and cancer
By IPP Bureau - September 30, 2021
The listings aim to address global health priorities, identifying the medicines that provide the greatest benefits, and which should be available and affordable for all
TCS to assist Sweden’s largest pharma retailer Apoteket in its digital transformation
By IPP Bureau - September 30, 2021
TCS to help Apoteket drive its digital transformation across sales channels and internal processes
Lifebit Biotech raises US $ 60 m in Series B funding
By IPP Bureau - September 30, 2021
Lifebit's accompanying suite of AI-powered end-to-end software solutions provide faster data insights, accelerate drug discovery pipelines, and improve clinical trials success
Fortis launches CATH LAB with 3D mapping Carto 7 machine
By IPP Bureau - September 30, 2021
Fortis Memorial Research Institute is the only hospital in India and South Asia to acquire the machine
Jubliant FoodWorks leads Rs 11 crore funding in Wellversed
By IPP Bureau - September 30, 2021
The global wellness market is valued at more than US $ 1.5 trillion, with annual growth of 5-10 per cent
Wyss Center receives CE mark for Epios Cloud software
By IPP Bureau - September 30, 2021
The cloud-based platform enables long-term brain monitoring towards personalized treatment
Glenmark receives marketing approval for Ryaltris in 13 countries across the EU and UK
By IPP Bureau - September 30, 2021
Ryaltris is a fixed dose combination nasal spray that combines an antihistamine (Olopatadine) with a steroid (Mometasone Furoate) for treatment of allergic rhinitis
UFlex partners with Hoffer Plastics and Mespack to launch recyclable mono-polymer hot fill pouches
By IPP Bureau - September 30, 2021
These pouches, manufactured at UFlex India plant, will be exported to American markets and will be majorly used for packing edible products
Roche launches cobas pure integrated solutions analyser
By IPP Bureau - September 30, 2021
Cobas pure provides clinical labs with access to more than 230 diagnostic tests across a wide range of disease areas including infectious diseases, oncology and cardiology
